Arteriosclerosis and Thrombosis, Vol 13, 1525-1532, Copyright © 1993 by American Heart Association

ARTICLES

Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL

M Ohgushi, K Kugiyama, K Fukunaga, T Murohara, S Sugiyama, E Miyamoto and H Yasue
Division of Cardiology, Kumamoto University School of Medicine, Japan.

The mechanism(s) of inhibition of endothelium-dependent relaxation (EDR) by oxidized low-density lipoprotein (Ox-LDL) was examined in isolated porcine coronary arteries and rabbit aortas. Incubation with Ox-LDL but not native LDL caused the inhibition of thrombin- or acetylcholine-induced EDR, whereas A23187-induced EDR was preserved after incubation with Ox-LDL. Lysophosphatidylcholine (lysoPC), which was abundant in Ox-LDL and was found to be transferred from Ox-LDL to endothelial cells, also caused the inhibition of EDR in response to thrombin or acetylcholine but not to A23187. Ox-LDL depleted of lysoPC, which was prepared by phospholipase B, failed to inhibit the vasorelaxation. Coincubation with staurosporine or calphostin C, potent inhibitors of protein kinase C, attenuated the EDR inhibition by Ox-LDL or lysoPC. Phorbol 12-myristate 13-acetate, a specific protein kinase C activator, caused the EDR inhibition, and its effect was attenuated by staurosporine or calphostin C. Furthermore, lysoPC was capable of activating protein kinase C purified from cultured porcine endothelial cells. In conclusion, protein kinase C activation plays a role in the inhibition of surface receptor-mediated EDR by Ox-LDL, and lysoPC transferred from Ox-LDL to endothelial cells may be involved in the activation of protein kinase C.

This article has been cited by other articles:

				R. P. Brandes Roads to Dysfunction: Argininase II Contributes to Oxidized Low-Density Lipoprotein-Induced Attenuation of Endothelial NO Production Circ. Res., October 27, 2006; 99(9): 918 - 920. [Full Text] [PDF]

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				T. H. Schindler, E. U. Nitzsche, T. Munzel, M. Olschewski, I. Brink, M. Jeserich, M. Mix, P. T. Buser, M. Pfisterer, U. Solzbach, et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration J. Am. Coll. Cardiol., September 3, 2003; 42(5): 814 - 822. [Abstract] [Full Text] [PDF]

				K. Cieslik, C.-M. Lee, J.-L. Tang, and K. K. Wu Transcriptional Regulation of Endothelial Nitric-oxide Synthase by an Interaction between Casein Kinase 2 and Protein Phosphatase 2A J. Biol. Chem., December 3, 1999; 274(49): 34669 - 34675. [Abstract] [Full Text] [PDF]

				T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF]

				B. V. Bassa, D. D. Roh, N. D. Vaziri, M. A. Kirschenbaum, and V. S. Kamanna Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma -1 and tyrosine kinase-Ras pathways Am J Physiol Renal Physiol, September 1, 1999; 277(3): F328 - F337. [Abstract] [Full Text] [PDF]

				J. F. KEANEY JR., D. I. SIMON, and J. E. FREEDMAN Vitamin E and vascular homeostasis: implications for atherosclerosis FASEB J, June 1, 1999; 13(9): 965 - 975. [Abstract] [Full Text]

				S. Sugiyama, K. Kugiyama, N. Ogata, H. Doi, Y. Ota, M. Ohgushi, T. Matsumura, H. Oka, and H. Yasue Biphasic Regulation of Transcription Factor Nuclear Factor-{kappa}B Activity in Human Endothelial Cells by Lysophosphatidylcholine Through Protein Kinase C–Mediated Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 568 - 576. [Abstract] [Full Text] [PDF]

				L. Zhao and R. L. Tackett Oxidized Low-Density Lipoprotein Inhibits Acetylcholine-Induced Vasorelaxation and Increases 5-HT-Induced Vasoconstriction in Isolated Human Saphenous Vein J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 637 - 643. [Abstract] [Full Text]

				D. A. Cox and M. L. Cohen Relationship between Phospholipase D Activation and Endothelial Vasomotor Dysfunction in Rabbit Aorta J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 305 - 311. [Abstract] [Full Text]

				A. Stiko, J. Regnstrom, P. K. Shah, B. Cercek, and J. Nilsson Active Oxygen Species and Lysophosphatidylcholine Are Involved in Oxidized Low Density Lipoprotein Activation of Smooth Muscle Cell DNA Synthesis Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 194 - 200. [Abstract] [Full Text]

				C. L. Cowan and R. P. Steffen Lysophosphatidylcholine Inhibits Relaxation of Rabbit Abdominal Aorta Mediated by Endothelium-Derived Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor Independent of Protein Kinase C Activation Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2290 - 2297. [Abstract] [Full Text]

				A. Zembowicz, J.-l. Tang, and K. K. Wu Transcriptional Induction of Endothelial Nitric Oxide Synthase Type III by Lysophosphatidylcholine J. Biol. Chem., July 14, 1995; 270(28): 17006 - 17010. [Abstract] [Full Text] [PDF]